Premium
Sustainable cytopathology in the precision medicine era: Exploring new sources for molecular testing in thyroid cytology specimens
Author(s) -
Nishino Michiya
Publication year - 2019
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.22107
Subject(s) - cytopathology , medicine , cytology , fine needle aspiration , pathology , molecular diagnostics , thyroid cancer , thyroid , biopsy , bioinformatics , biology
The growing demand for ancillary molecular testing on cytology and small biopsy specimens must be met with systematic and innovative ways to maximize diagnostic yield from limited amounts of tissue. In this issue of Cancer Cytopathology , Ye et al describe their analytic validation of supernatant fluid from centrifuged thyroid fine‐needle aspiration specimens (fluid that generally is discarded during routine processing) as the source of nucleic acid for targeted next‐generation sequencing for cancer‐related mutations.